Hepatosplenic T cell lymphoma screening: Difference between revisions
No edit summary |
Mahshid |
||
| Line 18: | Line 18: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Hepatology]] | |||
Latest revision as of 02:02, 27 November 2017
|
Hepatosplenic T cell lymphoma Microchapters |
|
Differentiating Hepatosplenic T cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatosplenic T cell lymphoma screening On the Web |
|
American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma screening |
|
Directions to Hospitals Treating Hepatosplenic T cell lymphoma |
|
Risk calculators and risk factors for Hepatosplenic T cell lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for hepatosplenic T cell lymphoma.[1]
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for hepatosplenic T cell lymphoma.[1]
References
- ↑ 1.0 1.1 Recommendations. U.S Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=hepatosplenic+T+cell+lymphoma. Accessed on February 23, 2016